Ultrasound-Guided Delivery of Thymidine Kinase–Nitroreductase Dual Therapeutic Genes By PEGylated-PLGA/PEI Nanoparticles for Enhanced Triple Negative Breast Cancer Therapy

Aim: Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype. Since no targeted therapy is available, gene-directed enzyme prodrug therapy (GDEPT) could be an attractive strategy for treating TNBC. Materials & methods: Polyethylene glycol (PEG)ylated-poly(lactic-co-glycolic a...

Full description

Saved in:
Bibliographic Details
Published in:Nanomedicine (London, England) England), 2018-05, Vol.13 (9), p.1051-1066
Main Authors: Devulapally, Rammohan, Lee, Taehwa, Barghava-Shah, Aarohi, Sekar, Thillai V, Foygel, Kira, Bachawal, Sunitha V, Willmann, Jürgen K, Paulmurugan, Ramasamy
Format: Article
Language:English
Subjects:
Breast cancer
Cancer therapies
Cytotoxicity
Deoxyribonucleic acid
DNA
Efficiency
Enzymes
Gene expression
Gene therapy
Kinases
MicroRNAs
Nanoparticles
Polyethylene glycol
Tumors
Ultrasonic imaging
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Aim: Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype. Since no targeted therapy is available, gene-directed enzyme prodrug therapy (GDEPT) could be an attractive strategy for treating TNBC. Materials & methods: Polyethylene glycol (PEG)ylated-poly(lactic-co-glycolic acid)/polyethyleneimine nanoparticles (PLGA/PEI NPs) were synthesized and complexed with TK–NTR fusion gene. Ultrasound (US) and microbubble (MB) mediated sonoporation was used for efficient delivery of the TK–NTR–DNA–NP complex to TNBC tumor in vivo for cancer therapy. Therapeutic effect was evaluated by treating TNBC cells in vitro and tumor xenograft in vivo by using prodrugs ganciclovir (GCV) and CB1954. Results: TNBC cells treated with GCV/CB1954 prodrugs after transfection of TK–NTR–DNA by PEGylated-PLGA/PEI NP resulted in high apoptotic-index. US–MB image-guided delivery of TK–NTR–DNA–NP complex displayed significant expression level of TK–NTR protein and showed tumor reduction when treated with GCV/CB1954 prodrugs in TNBC xenograft in vivo. Conclusion: US–MB image-guided delivery of TK–NTR gene by PEGylated-PLGA/PEI NPs could be a potential prodrug therapy for TNBC in the clinic.
ISSN:1743-5889
1748-6963
DOI:10.2217/nnm-2017-0328